Provivi develops biopesticides for agriculture, commercial, household, and public health pest management.
Provivi has raised $2.5M in total funding. The most recent round was Debt Financing. The last funding was announced in September 2026.
Provivi's investors include Temasek, Vivo Capital, National Science Foundation, Bill & Melinda Gates Foundation, Kairos Ventures.
Provivi is headquartered in Santa Monica, United States.
Provivi develops biopesticides for agriculture, commercial, household, and public health pest management.
Provivi is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Provivi — Funding & Investors." VCBacked, September 28, 2026, https://www.vcbacked.co/company/provivi. Accessed October 28, 2026.
VCBacked. (2026). Provivi — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/provivi
{{cite web |title=Provivi — Funding & Investors |url=https://www.vcbacked.co/company/provivi |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated